As of 2025-01-23, the Relative Valuation of Ocular Therapeutix Inc (OCUL) is (22.21) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.01 USD, the upside of Ocular Therapeutix Inc based on Relative Valuation is -377.2%.
The range of the Relative Valuation is (14.08) - (27.81) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.7x - 25.1x | 20.0x |
| Forward P/E multiples | 12.2x - 25.5x | 20.1x |
| Fair Price | (14.08) - (27.81) | (22.21) |
| Upside | -275.8% - -447.2% | -377.2% |
| Date | P/E |
| 2025-01-13 | -7.40 |
| 2025-01-10 | -7.40 |
| 2025-01-08 | -8.00 |
| 2025-01-07 | -8.19 |
| 2025-01-06 | -8.01 |
| 2025-01-03 | -7.90 |
| 2025-01-02 | -7.88 |
| 2024-12-31 | -7.70 |
| 2024-12-30 | -7.53 |
| 2024-12-27 | -7.61 |
| 2024-12-26 | -7.70 |
| 2024-12-24 | -7.51 |
| 2024-12-23 | -7.72 |
| 2024-12-20 | -7.67 |
| 2024-12-19 | -7.62 |
| 2024-12-18 | -7.61 |
| 2024-12-17 | -8.13 |
| 2024-12-16 | -8.10 |
| 2024-12-13 | -7.84 |
| 2024-12-12 | -8.02 |
| 2024-12-11 | -8.62 |
| 2024-12-10 | -8.51 |
| 2024-12-09 | -8.43 |
| 2024-12-06 | -8.68 |
| 2024-12-05 | -8.28 |
| 2024-12-04 | -8.55 |
| 2024-12-03 | -8.56 |
| 2024-12-02 | -8.81 |
| 2024-11-29 | -8.92 |
| 2024-11-27 | -9.07 |
| 2024-11-26 | -8.79 |
| 2024-11-25 | -8.20 |
| 2024-11-22 | -7.96 |
| 2024-11-21 | -7.68 |
| 2024-11-20 | -7.92 |
| 2024-11-19 | -8.04 |
| 2024-11-18 | -7.84 |
| 2024-11-15 | -8.26 |
| 2024-11-14 | -8.95 |
| 2024-11-13 | -9.56 |
| 2024-11-12 | -9.56 |
| 2024-11-11 | -9.88 |
| 2024-11-08 | -10.01 |
| 2024-11-07 | -9.72 |
| 2024-11-06 | -9.87 |
| 2024-11-05 | -9.53 |
| 2024-11-04 | -9.26 |
| 2024-11-01 | -9.37 |
| 2024-10-31 | -9.50 |
| 2024-10-30 | -9.99 |